标题
Rifaximin for the treatment of diarrhea-predominant irritable bowel syndrome
作者
关键词
-
出版物
Expert Review of Gastroenterology & Hepatology
Volume 10, Issue 4, Pages 431-442
出版商
Informa UK Limited
发表日期
2016-01-12
DOI
10.1586/17474124.2016.1140571
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Ramosetron Reduces Symptoms of Irritable Bowel Syndrome With Diarrhea and Improves Quality of Life in Women
- (2016) Shin Fukudo et al. GASTROENTEROLOGY
- Review article: the antimicrobial effects of rifaximin on the gut microbiota
- (2015) H. L. DuPont ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Review article: the potential mechanisms of action of rifaximin in the management of inflammatory bowel diseases
- (2015) R. B. Sartor ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Deviations in human gut microbiota: a novel diagnostic test for determining dysbiosis in patients with IBS or IBD
- (2015) C. Casén et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Altered Colonic Bacterial Fermentation as a Potential Pathophysiological Factor in Irritable Bowel Syndrome
- (2015) Tamar Ringel-Kulka et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Burden of Gastrointestinal, Liver, and Pancreatic Diseases in the United States
- (2015) Anne F. Peery et al. GASTROENTEROLOGY
- Irritable Bowel Syndrome
- (2015) William D. Chey et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Molecular assessment of differences in the duodenal microbiome in subjects with irritable bowel syndrome
- (2015) Evangelos Giamarellos-Bourboulis et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Heme oxygenase-1 protects rat liver against warm ischemia/reperfusion injuryviaTLR2/TLR4-triggered signaling pathways
- (2015) Han-Fei Huang WORLD JOURNAL OF GASTROENTEROLOGY
- Systematic review with meta-analysis: the effects of rifaximin in hepatic encephalopathy
- (2014) N. Kimer et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Safety and tolerability of rifaximin for the treatment of irritable bowel syndrome without constipation: a pooled analysis of randomised, double-blind, placebo-controlled trials
- (2014) P. Schoenfeld et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Review article: the economic impact of the irritable bowel syndrome
- (2014) C. Canavan et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The Effect of Fiber Supplementation on Irritable Bowel Syndrome: A Systematic Review and Meta-analysis
- (2014) Paul Moayyedi et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Effect of Antidepressants and Psychological Therapies, Including Hypnotherapy, in Irritable Bowel Syndrome: Systematic Review and Meta-Analysis
- (2014) Alexander C Ford et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- American College of Gastroenterology Monograph on the Management of Irritable Bowel Syndrome and Chronic Idiopathic Constipation
- (2014) Alexander C Ford et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Efficacy of Prebiotics, Probiotics and Synbiotics in Irritable Bowel Syndrome and Chronic Idiopathic Constipation: Systematic Review and Meta-analysis
- (2014) Alexander C Ford et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Pregnane X receptor agonists enhance intestinal epithelial wound healing and repair of the intestinal barrier following the induction of experimental colitis
- (2014) Joshua Terc et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- In vitro activity of rifaximin against isolates from patients with small intestinal bacterial overgrowth
- (2014) Aikaterini Pistiki et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Uncomplicated Diverticular Disease: Innate and Adaptive Immunity in Human Gut Mucosa before and after Rifaximin
- (2014) Rossella Cianci et al. Journal of Immunology Research
- Use of Rifamycin Drugs and Development of Infection by Rifamycin-Resistant Strains of Clostridium difficile
- (2013) Jamie S. Huang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Rifaximin Is Safe and Well Tolerated for Long-term Maintenance of Remission From Overt Hepatic Encephalopathy
- (2013) Kevin D. Mullen et al. Clinical Gastroenterology and Hepatology
- Eluxadoline Benefits Patients With Irritable Bowel Syndrome With Diarrhea in a Phase 2 Study
- (2013) Leonard S. Dove et al. GASTROENTEROLOGY
- Rifaximin Alters Intestinal Bacteria and Prevents Stress-Induced Gut Inflammation and Visceral Hyperalgesia in Rats
- (2013) Dabo Xu et al. GASTROENTEROLOGY
- A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea
- (2013) Klara Garsed et al. GUT
- Modulation of the Metabiome by Rifaximin in Patients with Cirrhosis and Minimal Hepatic Encephalopathy
- (2013) Jasmohan S. Bajaj et al. PLoS One
- Rifaximin treatment for the irritable bowel syndrome with a positive lactulose hydrogen breath test improves symptoms for at least 3 months
- (2012) P. Meyrat et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Randomised clinical trials: linaclotide phase 3 studies in IBS-C - a prespecified further analysis based on European Medicines Agency-specified endpoints
- (2012) E. M. M. Quigley et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis
- (2012) Rebecca M. Lovell et al. Clinical Gastroenterology and Hepatology
- Update on rifampin, rifabutin, and rifapentine drug interactions
- (2012) Anne M. Baciewicz et al. CURRENT MEDICAL RESEARCH AND OPINION
- The Prevalence of Overgrowth by Aerobic Bacteria in the Small Intestine by Small Bowel Culture: Relationship with Irritable Bowel Syndrome
- (2012) Emmannouil Pyleris et al. DIGESTIVE DISEASES AND SCIENCES
- Intestinal microbiota in functional bowel disorders: a Rome foundation report
- (2012) Magnus Simrén et al. GUT
- Irritable bowel syndrome: Physicians' awareness and patients' experience
- (2012) Linda Bjork Olafsdottir WORLD JOURNAL OF GASTROENTEROLOGY
- Physical Activity Improves Symptoms in Irritable Bowel Syndrome: A Randomized Controlled Trial
- (2011) Elisabet Johannesson et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- The Efficacy and Safety of Rifaximin for the Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis
- (2011) Stacy B Menees et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Effects of Rifaximin Treatment and Retreatment in Nonconstipated IBS Subjects
- (2011) Mark Pimentel et al. DIGESTIVE DISEASES AND SCIENCES
- Mucosal inflammation as a potential etiological factor in irritable bowel syndrome: a systematic review
- (2011) Alexander C. Ford et al. JOURNAL OF GASTROENTEROLOGY
- Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation
- (2011) Mark Pimentel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bile Acids Improve the Antimicrobial Effect of Rifaximin
- (2010) C. Darkoh et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Combined oro-caecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testing detects oro-caecal transit, not small intestinal bacterial overgrowth in patients with IBS
- (2010) D. Yu et al. GUT
- Rifaximin-induced alteration of virulence of diarrhoea-producing Escherichia coli and Shigella sonnei
- (2010) Zhi-Dong Jiang et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome
- (2010) Derrick K Ong et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Therapeutic Role of Rifaximin in Inflammatory Bowel Disease: Clinical Implication of Human Pregnane X Receptor Activation
- (2010) J. Cheng et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions
- (2010) Lena Öhman et al. Nature Reviews Gastroenterology & Hepatology
- Efficacy of 5-HT3 Antagonists and 5-HT4 Agonists in Irritable Bowel Syndrome: Systematic Review and Meta-Analysis
- (2009) Alexander C Ford et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Pretreatment of Epithelial Cells with Rifaximin Alters Bacterial Attachment and Internalization Profiles
- (2009) E. L. Brown et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: Systematic Review and Meta-analysis
- (2009) Alexander C. Ford et al. Clinical Gastroenterology and Hepatology
- Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome - results of two randomized, placebo-controlled studies
- (2008) D. A. DROSSMAN et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Irritable Bowel Syndrome: A 10-Yr Natural History of Symptoms and Factors That Influence Consultation Behavior
- (2008) Alexander C. Ford et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- A Phase II Trial of the Novel Serotonin Type 3 Receptor Antagonist Ramosetron in Japanese Male and Female Patients with Diarrhea-Predominant Irritable Bowel Syndrome
- (2008) K. Matsueda et al. DIGESTION
- Rifaximin versus nonabsorbable disaccharides in the management of hepatic encephalopathy: a meta-analysis
- (2008) Qian Jiang et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- T1390 Rifaximin for the Treatment of Diarrhea-Associated Irritable Bowel Syndrome: Short Term Treatment Leading to Long Term Sustained Response
- (2008) Anthony Lembo et al. GASTROENTEROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started